Skip to main content
TipRanks
Go Ultimate75% OFF

Fulgent Genetics (FLGT) Stock Statistics & Valuation Metrics

1,645 Followers

Total Valuation

Fulgent Genetics has a market cap or net worth of $676.40M. The enterprise value is $320.97M.

Market Cap
$676.40M
Enterprise Value
$320.97M

Share Statistics

Fulgent Genetics has 27,939,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
27,939,000
Owned by Insiders
39.41%
Owned by Institutions
42.55%

Financial Efficiency

Fulgent Genetics’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -7.09%.

Return on Equity (ROE)
-0.05
Return on Assets (ROA)
-0.05
Return on Invested Capital (ROIC)
-7.09%
Return on Capital Employed (ROCE)
-0.08
Revenue Per Employee
245.38K
Profits Per Employee
-46.02K
Employee Count
1,315
Asset Turnover
0.27
Inventory Turnover
18.09

Valuation Ratios

The current PE Ratio of Fulgent Genetics is -7.80. Fulgent Genetics’s PEG ratio is 0.12.

PE Ratio
-7.80
PS Ratio
2.04
PB Ratio
0.67
Price to FCF
-480.75
Price to Operating Cash Flow
46.19
PEG Ratio
0.12

Income Statement

In the last 12 months, Fulgent Genetics had revenue of 322.67M and earned -60.51M in profits. Earnings per share was -1.97.

Revenue
322.67M
Gross Profit
130.88M
Operating Income
-91.10M
Pretax Income
-70.03M
Net Income
-60.51M
EBITDA
-45.83M
Earnings Per Share (EPS)
-1.97

Cash Flow

In the last 12 months, operating cash flow was 14.43M and capital expenditures -15.83M, giving a free cash flow of -1.40M billion.

Operating Cash Flow
14.43M
Free Cash Flow
-1.40M
Free Cash Flow per Share
-0.05

Dividends & Yields

Fulgent Genetics pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-0.21%
Earnings Yield
-13.57%

Stock Price Statistics

Beta
0.59
52-Week Price Change
-15.97%
50-Day Moving Average
21.38
200-Day Moving Average
19.02
Relative Strength Index (RSI)
59.52
Average Volume (3m)
327.04K

Important Dates

Fulgent Genetics upcoming earnings date is Feb 26, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 05, 2026
Next Earnings Date
Feb 26, 2027
Ex-Dividend Date
―

Financial Position

Fulgent Genetics as a current ratio of 6.48, with Debt / Equity ratio of 0.69%

Current Ratio
6.48
Quick Ratio
6.35
Debt to Market Cap
0.00
Net Debt to EBITDA
0.93
Interest Coverage Ratio
-1214.61

Taxes

In the past 12 months, Fulgent Genetics has paid -8.39M in taxes.

Income Tax
-8.39M
Effective Tax Rate
0.12

Enterprise Valuation

Fulgent Genetics EV to EBITDA ratio is -8.20, with an EV/FCF ratio of -422.75.

EV to Sales
1.79
EV to EBITDA
-8.20
EV to Free Cash Flow
-422.75
EV to Operating Cash Flow
41.02

Balance Sheet

Fulgent Genetics has $292.74M in cash and marketable securities with $1.96M in debt, giving a net cash position of $290.78M billion.

Cash & Marketable Securities
$292.74M
Total Debt
$1.96M
Net Cash
$290.78M
Net Cash Per Share
$10.41
Tangible Book Value Per Share
$28.34

Margins

Gross margin is 33.82%, with operating margin of -38.55%, and net profit margin of -27.53%.

Gross Margin
33.82%
Operating Margin
-38.55%
Pretax Margin
-29.97%
Net Profit Margin
-27.53%
EBITDA Margin
-21.85%
EBIT Margin
-29.90%

Analyst Forecast

The average price target for Fulgent Genetics is $25.00, which is 11.43% higher than the current price. The consensus rating is Neutral

Price Target
$25.00
Price Target Upside
3.26% Upside
Analyst Consensus
Neutral
Analyst Count
1
Revenue Growth Forecast
4.67%
EPS Growth Forecast
-120.44%

Scores

Smart Score
5
AI Score
60